The course builds on approaches and technologies that we are currently developing in the NTNU DrugLogics initiative, where we use the logical modelling formalism for predicting the outcome of chemical perturbations (cancer drugs) on cancer cell fate decisions. This approach combines knowledge management, logical model construction and computational simulation with experimental assays and hypothesis testing for pre-clinical (biotechnological) drug development and clinical decision support. The course will exemplify how such approaches can be used in both the biotechnological and biomedical sectors such as pre-clinical drug discovery and repurposing, and clinical development of diagnosis and (combinatorial) treatment of cancer.
Application deadline: 23 July
If you are a member of Digital Life Norway Research School, all your costs related to course attendance can be covered if you apply for a travel grant.